Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel Bouganim

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Circulation|September 14, 2020
Response by Khosrow-Khavar et al to Letters Regarding Article, "Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study"Farzin Khosrow-Khavar, Kristian B Filion, Nathaniel Bouganim, et al.
American Journal of Epidemiology|April 28, 2020
Cardiotoxicity of Use of Sequential Aromatase Inhibitors in Women With Breast CancerFarzin Khosrow-Khavar, Nathaniel Bouganim, Kristian B Filion, et al.
Circulation|February 18, 2020
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort StudyFarzin Khosrow-Khavar, Kristian B Filion, Nathaniel Bouganim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 16, 2026
Practical management of antineoplastic-induced nausea and vomiting from antibody-drug conjugates: Insights from a Canadian expert panelKatarzyna J Jerzak, Stephanie Snow, Jan-Willem Henning, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2010
Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasisProsanto Chaudhury, Mazen Hassanain, Nathaniel Bouganim, et al.
CMAJ Open|June 5, 2021
Evaluation of the quality of mammographic breast positioning: a quality improvement studyJulie Rouette, Noémie Elfassy, Nathaniel Bouganim, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System MetastasesDavid J H Bian, Sara F Cohen, Anna-Maria Lazaratos, et al.
Epidemiology (Cambridge, Mass.)|April 14, 2020
Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with DiabetesChristina Santella, Hui Yin, Blánaid M Hicks, et al.
JCO Precision Oncology|January 7, 2022
Metastatic Large-Cell Neuroendocrine Lung Carcinoma With ALK Fusion Oncogene With Partial Response to AlectinibAndréanne Leblanc, Scott Owen, Pierre Olivier Fiset, et al.
Journal of Bone Oncology|February 25, 2016
De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologistsBrian Hutton, Christina Addison, Sasha Mazzarello, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Circulation|September 14, 2020
Response by Khosrow-Khavar et al to Letters Regarding Article, "Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study"Farzin Khosrow-Khavar, Kristian B Filion, Nathaniel Bouganim, et al.
American Journal of Epidemiology|April 28, 2020
Cardiotoxicity of Use of Sequential Aromatase Inhibitors in Women With Breast CancerFarzin Khosrow-Khavar, Nathaniel Bouganim, Kristian B Filion, et al.
Circulation|February 18, 2020
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort StudyFarzin Khosrow-Khavar, Kristian B Filion, Nathaniel Bouganim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 16, 2026
Practical management of antineoplastic-induced nausea and vomiting from antibody-drug conjugates: Insights from a Canadian expert panelKatarzyna J Jerzak, Stephanie Snow, Jan-Willem Henning, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2010
Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasisProsanto Chaudhury, Mazen Hassanain, Nathaniel Bouganim, et al.
CMAJ Open|June 5, 2021
Evaluation of the quality of mammographic breast positioning: a quality improvement studyJulie Rouette, Noémie Elfassy, Nathaniel Bouganim, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System MetastasesDavid J H Bian, Sara F Cohen, Anna-Maria Lazaratos, et al.
Epidemiology (Cambridge, Mass.)|April 14, 2020
Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with DiabetesChristina Santella, Hui Yin, Blánaid M Hicks, et al.
JCO Precision Oncology|January 7, 2022
Metastatic Large-Cell Neuroendocrine Lung Carcinoma With ALK Fusion Oncogene With Partial Response to AlectinibAndréanne Leblanc, Scott Owen, Pierre Olivier Fiset, et al.
Journal of Bone Oncology|February 25, 2016
De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologistsBrian Hutton, Christina Addison, Sasha Mazzarello, et al.
Pageof 8